BioSpace News Archive

Samsung Bioepis’ BRENZYS™ becomes available in Brazil through Brazil’s public health system, Sistema Único de Saúde

Translating novel triplex gene editing technology for patients with genetic disorders

Morgan Stanley Global Healthcare Conference on Wednesday, September 11, 2019 at 12:15 p.m. ET.

The Wyss Institute for Biologically Inspired Engineering at Harvard University and Miraki Innovation have unveiled BOA Biomedical Inc., a company that aims to solve the global healthcare demand for a device that rapidly diagnoses and treats infectious diseases, focusing specifically on sepsis and antibiotic-resistant infections.

ClearLight Biotechnologies, LLC announced today the execution of an exclusive world-wide license agreement to develop and commercialize the 3D tissue clearing technology, CRYSTAL, invented by Professor Adriano Aguzzi, M.D, Ph.D., and Daniel Kirschenbaum, M.D, Ph.D. at the University of Zurich and the University Hospital Zurich.

The global ophthalmic perimeters market size is poised to reach USD 52.37 million by 2023, according to a new report by Technavio, progressing at a CAGR of over 4% during the forecast period.

American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer: Advances in Science and Clinical Care, which took place September 6-9, 2019, at the Westin Copley Place in Boston, Massachusetts.

On September 9th, Cannamedical® Pharma GmbH, a leading cannabis distributor and one of the best-known medicinal cannabis brands in Germany and the European Union, imported from Portugal to Germany, the largest quantity of medicinal cannabis ever transported within the European Union.

Multiple Research Projects Analyze Genomic Data Sets to Understand Disease Progression and Therapeutic Resistance

The global urology laser surgical devices market size is poised to reach USD 129.16 million by 2023, according to a new report by Technavio, progressing at a CAGR of close to 7% during the forecast period.